CYCN vs DCOY

Cyclerion Therapeutics, Inc. vs Decoy Therapeutics Inc. — Valuation Comparison 2026

CYCN

Pharmaceutical Preparations
Cyclerion Therapeutics, Inc.
Quality
5.5
out of 10
Value Trap
24
SAFE
Price
$3.15
Last close
Models
9/13
Active
VS

DCOY

Pharmaceutical Preparations
Decoy Therapeutics Inc.
Quality
3.7
out of 10
Value Trap
39
LOW
Price
$8.92
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType CYCN Fair ValueCYCN Upside DCOY Fair ValueDCOY Upside
Bayesian DCF Intrinsic $1.20 -61.9% $9.54 +6.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.45 -86.2% $0.72 -87.8%
Dynamic NAV Asset-Based $8.67 +175.3% $20.47 +129.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CYCN vs DCOY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CYCN vs DCOY — Which Stock Is More Undervalued?

CYCN scores higher with a 5.5/10 quality rating vs DCOY's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cyclerion Therapeutics, Inc. (CYCN) and Decoy Therapeutics Inc. (DCOY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CYCN currently trades at $3.15 with a QOC of 5.5/10, while DCOY trades at $8.92 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).